Medtech News

Major European Medtech Summit in Dublin

April 2018.  Seroba Life Sciences is pleased to announce that it will sponsor a major European Medtech Summit in Dublin during April.  The conference, now in its 6th year, will be held at the Shelbourne Hotel from 17th to 19th of April.

500 delegates from around the world are expected to attend the Summit, including many innovative Irish medtech companies seeking funding for the next phase of their development.   40 Venture Capital firms with funds of over €6 Billion to invest in promising technologies will gather at the Summit where more than 40 start-ups will present.

The 3-day agenda also includes presentations and Q&A sessions with key opinion leaders in the medtech industry and once again the final of the hugely popular competition for start-ups – MedTech Innovator – will take place during the conference.   Industry giants like Johnson and Johnson, Medtronic, Boston Scientific and Baxter will also be in Dublin for the Summit, which is considered the pre-eminent medtech investment event in Europe.

The conference features numerous break-out rooms where medtech companies whose presentations catch the eye of investors in the main auditorium can go to discuss their innovations and plans in greater depth and in private.  As a side-bar to the conference, the Royal College of Surgeons (RCSI) and Trinity College Dublin will host a pre-conference event on 16th April at 6.30pm, featuring presentations on the role of the clinician in medical device innovation.

For further information about the conference, which is organised by Medtech Strategist, please see https://www.innovationinmedtech.com/conference/ or contact Seroba Life Sciences on +35316334028.

Recent Articles

Endotronix News

Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial

LISLE, IL – JULY 15, 2019 – Endotronix, Inc., a digital health and medical technology company dedicated to advancing the […]

Read More
Home V2

Seroba Invests in Storm Therapeutics

20 May 2019.  STORM Therapeutics (“STORM”), the drug discovery company tackling disease through modulating RNA modifying enzymes, has announced that […]

Read More
Quanta SC+

Quanta SC+ confirmed as safe and easy to use

Alcester, Warwickshire, UK, 15 April 2019.  Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a pioneering medical […]

Read More
Fusion

Fusion Raises $105m in Series B Financing

April 2nd 2019. Hamilton, Canada and Dublin, Ireland.  Seroba’s portfolio company, Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top